|
LncRNA
|
Tumor suppressor
|
Oncogene
|
CSC properties
|
|---|
|
AK139328
|
−
|
+
|
N/D
|
|
BANCR
|
−
|
+
|
+
|
|
CASC2
|
+
|
−
|
N/D
|
|
FOXD2-AS1
|
−
|
+
|
+
|
|
GAS5
|
+
|
−
|
N/D
|
|
H19
|
−
|
+
|
N/D
|
|
HCP5
|
−
|
+
|
N/D
|
|
HOTAIR
|
+
|
−
|
+
|
|
HOTAIRM1
|
−
|
+
|
N/D
|
|
KLHL14-AS
|
+
|
−
|
N/D
|
|
Linc00210
|
−
|
+
|
N/D
|
|
LINC00312
|
+
|
−
|
N/D
|
|
LOC100507661
|
−
|
+
|
N/D
|
|
MALAT1
|
−
|
+
|
+
|
|
MANCR
|
−
|
+
|
+
|
|
MIR22HG
|
+
|
−
|
N/D
|
|
NEAT1
|
−
|
+
|
N/D
|
|
PAR5
|
+
|
−
|
+
|
|
PCA3
|
−
|
+
|
N/D
|
|
PTCSC3
|
+
|
−
|
+
|
|
PVT1
|
−
|
+
|
+
|
|
ROR
|
−
|
+
|
+
|
|
SNHG15
|
+
|
−
|
N/D
|
|
SNHG7
|
−
|
+
|
N/D
|
|
TNRC6C-AS1
|
−
|
+
|
N/D
|
|
TUG1
|
−
|
+
|
+
|
|
UCA1
|
−
|
+
|
N/D
|
|
XIST
|
−
|
+
|
N/D
|
|
ZFAS1
|
−
|
+
|
N/D
|
- N/D, not detected; BANCR, BRAF-activated non-protein coding RNA; CASC2, cancer susceptibility candidate 2; CSC, cancer stem cell; FOXD2-AS1, FOXD2 adjacent opposite strand RNA 1; GAS5, growth arrest special 5; HCP5, HLA complex P5; HOTAIR, HOX transcript antisense RNA; HOTAIRM1, hox antisense intergenic RNA myeloid 1; Klhl14, kelch like family member 14; Linc00210, long intergenic non-protein coding RNA 210; LINC00312, long intergenic non-protein coding RNA 312; LncRNA, long noncoding RNA, MALAT1: metastasis-associated lung adenocarcinoma transcript 1; MANCR, mitotically associated long non coding RNA; MIR22HG, MIR22 host gene; NEAT1, nuclear paraspeckle assembly transcript 1; PAR5, Prader Wili/Angelman region RNA 5; PCA3, prostate cancer antigen 3; PTCSC3, papillary thyroid carcinoma susceptibility candidate 3; PVT1, plasmacytoma variant translocation 1; ROR, regulator of reprogramming; SNHG15, small nucleolar RNA host gene 15; SNHG7, small nucleolar RNA host gene 7; TNRC6C-AS1, TNRC6C antisense RNA 1; TUG1, taurine up-regulated gene 1;UCA1, urothelial carcinoma-associated 1; XIST, X inactive specific transcript; ZFAS1, ZNFX1 antisense RNA 1
